OOIR: Observatory of International Research

Papers

(The H4-Index of Europace is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Zero-fluoroscopy trans-septal puncture and catheter ablation of a left atrial tachycardia in a pregnant woman with a prosthetic mitral valve	252
How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?	247
Atrioventricular dromotropathy: an important substrate for complete resynchronization therapy—Authors’ reply	245
Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance	244
Administrative data confirm safety of same-day discharge following catheter ablation of atrial fibrillation: all good or is there a fly in the ointment?	222
Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium	182
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the nat	175
Impact of sodium-glucose co-transporter inhibitors on cardiac autonomic function and mortality: no time to die	157
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study	132
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review	112
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	96
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	90
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study	81
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	80
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	78
Carbon footprint of atrial fibrillation catheter ablation	77
Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	73
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	72
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey	72
Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial	72
Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application	66
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	66
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	66
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	65
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	65

Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	64
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	62
Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V	61
High-density sequential mapping of repetitive atrial conduction patterns during atrial fibrillation	58
First experience of focal pulsed field ablation for premature ventricular contractions	57
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	56
The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter	54
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	54
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	53
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	51
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	50
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	50
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	49
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	49
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	49
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	49
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	48
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	47
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	47
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	47
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	47
Impaired heart rate variability triangular index predicts stroke and systemic embolism in patients with atrial fibrillation	46